Dr. Vitaly Margulis, MD
What this data tells you about Dr. Margulis
Dr. Vitaly Margulis is an urology physician in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Margulis performed 3,516 Medicare services across 1,096 unique beneficiaries.
Between the years covered by Open Payments, Dr. Margulis received a total of $495,808 from 39 pharmaceutical and/or device companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Margulis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, docetaxel, 1 mg | 1,880 | $0 | $4 |
| Office visit, established patient (30-39 min) | 471 | $89 | $344 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 240 | $3 | $395 |
| Diagnostic exam of bladder and urethra using an endoscope | 150 | $177 | $837 |
| Urinalysis, manual | 131 | $3 | $18 |
| New patient office visit, complex (60-74 min) | 120 | $138 | $664 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 99 | $129 | $2,030 |
| Instillation of anti-cancer drug into bladder | 50 | $68 | $468 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 40 | $719 | $7,081 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 38 | $199 | $1,356 |
| Office visit, established patient, complex (40-54 min) | 38 | $120 | $464 |
| Bladder ultrasound after voiding | 32 | $8 | $80 |
| Other procedure on bladder using an endoscope | 28 | $1,529 | $8,389 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 27 | $258 | $3,223 |
| Partial removal of kidney using an endoscope | 23 | $1,144 | $5,836 |
| Insertion of stent in ureter using an endoscope | 23 | $96 | $2,172 |
| Electronic assessment of bladder emptying | 22 | $10 | $340 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 22 | $26 | $143 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $16 | $75 |
| Destruction and/or removal of large growth of bladder using an endoscope | 17 | $293 | $2,128 |
| Office visit, established patient (20-29 min) | 17 | $66 | $232 |
| Imaging of urinary tract following injection of a contrast agent | 16 | $18 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $52 | $138 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Margulis is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Margulis experienced with injection, docetaxel, 1 mg?
Does Dr. Margulis receive payments from pharmaceutical companies?
How do Dr. Margulis's costs compare to other urology physicians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology